Learn about:
- BET
- MICHAEL
![Real KRYSTEXXA patient, Bet](/images/Efficacy-Safety/bet.png)
Meet Bet
A real patient.
A real transformation.
- 43-year-old husband and father; loves spending time with his children
- 20-year history of gout; had to stop working construction
- Oral urate-lowering therapies did not reduce tophi or provide meaningful relief
- Rheumatologist started him on KRYSTEXXA; saw noticeable reduction in visible tophi, flares, and pain
KRYSTEXXA is not for the management of pain. The optimal treatment duration for KRYSTEXXA has not been established. Individual results may vary.
sUA, serum uric acid.
Hear Bet’s Story
![A picture of tophi in fingers of KRYSTEXXA patient, Bet, in April 2019 before treatment](/images/Nurse/picture-of-tophi-in-fingers.png)
April 2019
Before KRYSTEXXA
sUA 14.3 mg/dL
![A picture of KRYSTEXXA patient, Bet's, fingers in September 2021, with visible improvement](/images/Nurse/post-treatment-fingers.png)
September 2021
KRYSTEXXA with methotrexate sUA <1.5 mg/dL
Individual results may vary.
KRYSTEXXA is not for the management of pain. The optimal treatment duration for KRYSTEXXA has not been established. Individual results may vary.
sUA, serum uric acid.
Hear Bet’s Story
![A picture of tophi in fingers of KRYSTEXXA patient, Bet, in April 2019 before treatment](/images/Nurse/picture-of-tophi-in-fingers.png)
April 2019
Before KRYSTEXXA
sUA 14.3 mg/dL
![A picture of KRYSTEXXA patient, Bet's, fingers in September 2021, with visible improvement](/images/Nurse/post-treatment-fingers.png)
September 2021
KRYSTEXXA with
methotrexate
sUA <1.5 mg/dL
Individual results may vary.
![Real KRYSTEXXA patient, Michael](/images/Nurse/michael.png)
Meet Michael
A real patient.
A real transformation.
- Married with 4 children, architect for 35 years
- 30-year history of gout; flares and tophi impacted his work and leisure activities
- Referred to a nephrologist who started Michael on KRYSTEXXA with methotrexate
- Reduction in flares and tophi, including complete resolution of marble-sized tophus on his right hand
Individual results may vary.
Hear Michael’s Story
![A picture of tophi in fingers of KRYSTEXXA patient, Michael, in January 2021 before treatment](/images/Nurse/gouty-tophi-in-fingers.png)
January 2021
Before KRYSTEXXA
sUA 10.3 mg/dL
![A picture of KRYSTEXXA patient, Michael's, fingers in April 2022, with visible improvement](/images/Nurse/post-treatment-fingers-michael.png)
April 2022
KRYSTEXXA with methotrexate sUA <1.5 mg/dLsUA <1.5 mg/dL
Individual results may vary.
Optimal treatment duration has not been established.
sUA, serum uric acid.
Hear Michael’s Story
![A picture of tophi in fingers of KRYSTEXXA patient, Michael, in January 2021 before treatment](/images/Nurse/gouty-tophi-in-fingers.png)
January 2021
Before KRYSTEXXA
sUA 10.3 mg/dL
![A picture of KRYSTEXXA patient, Michael's, fingers in April 2022, with visible improvement](/images/Nurse/post-treatment-fingers-michael.png)
April 2022
KRYSTEXXA with
methotrexate
sUA <1.5 mg/dL
Individual results may vary.
Optimal treatment duration has not been established.